|
Characteristics
|
Patients (cases (%))
|
|---|
|
Gender
|
|
Male
|
39 (41.1)
|
|
Female
|
56 (58.9)
|
|
Age, years
|
54.4 ± 12.1
|
|
TNM staging of ENETS in 2006
|
|
T1
|
34 (35.8)
|
|
T2
|
28 (29.5)
|
|
T3
|
21 (22.1)
|
|
T4
|
12 (12.6)
|
|
N0
|
80 (84.2)
|
|
N1
|
15 (15.8)
|
|
M0
|
80 (84.2)
|
|
M1
|
15 (15.8)
|
|
Grading classifications of WHO 2010
|
|
NET G1
|
52 (54.7)
|
|
NET G2
|
32 (33.7)
|
|
NEC G3
|
11 (11.6)
|
|
Tumor thrombus
|
|
Yes
|
6 (6.3)
|
|
No
|
89 (93.7)
|
|
Surgical resection
|
|
Radical
|
89 (93.7)
|
|
Nonradical
|
6 (6.3)
|
|
Functioning tumor
|
|
Yes
|
21 (22.1)
|
|
No
|
74 (77.9)
|
|
Blood loss volume, ml
|
312.8 ± 661.2
|
|
Operation duration, min
|
302.0 ± 158.0
|
|
Surgical approaches
|
|
Distal pancreatectomy
|
47 (49.5)
|
|
Local resection of pancreatic tumor
|
19 (20.0)
|
|
Pancreaticoduodenectomy
|
27 (28.4)
|
|
Total pancreatectomy
|
2 (2.1)
|
-
NET neuroendocrine tumor, NEC neuroendocrine carcinoma
